Carrington, E. M., Vikstrom, I. B., Light, A., Sutherland, R. M., Londrigan, S. L., Mason, K. D., . . . Tarlinton, D. M. (2010). BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. National Academy of Sciences.
Citação norma ChicagoCarrington, Emma M., Ingela B. Vikstrom, Amanda Light, Robyn M. Sutherland, Sarah L. Londrigan, Kylie D. Mason, David C. S. Huang, Andrew M. Lew, and David M. Tarlinton. BH3 Mimetics Antagonizing Restricted Prosurvival Bcl-2 Proteins Represent Another Class of Selective Immune Modulatory Drugs. National Academy of Sciences, 2010.
MLA citiranjeCarrington, Emma M., et al. BH3 Mimetics Antagonizing Restricted Prosurvival Bcl-2 Proteins Represent Another Class of Selective Immune Modulatory Drugs. National Academy of Sciences, 2010.